Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-cash Items (2022 - 2025)

Lexaria Bioscience's Non-cash Items history spans 4 years, with the latest figure at $26625.0 for Q4 2025.

  • For Q4 2025, Non-cash Items fell 74.85% year-over-year to $26625.0; the TTM value through Nov 2025 reached $26625.0, down 74.85%, while the annual FY2025 figure was $206.0, 99.98% down from the prior year.
  • Non-cash Items for Q4 2025 was $26625.0 at Lexaria Bioscience, up from $206.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $977561.0 in Q2 2024 and bottomed at $206.0 in Q3 2025.
  • The 4-year median for Non-cash Items is $46375.0 (2022), against an average of $271533.2.
  • The largest annual shift saw Non-cash Items soared 26898.86% in 2024 before it crashed 99.98% in 2025.
  • A 4-year view of Non-cash Items shows it stood at $46375.0 in 2022, then fell by 0.75% to $46025.0 in 2023, then surged by 130.02% to $105869.0 in 2024, then tumbled by 74.85% to $26625.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Non-cash Items are $26625.0 (Q4 2025), $206.0 (Q3 2025), and $3000.0 (Q2 2025).